Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study.
Focus (Am Psychiatr Publ)
; 17(1): 55-65, 2019 Jan.
Article
em En
| MEDLINE
| ID: mdl-32015715
(Reprinted with permission from AmJ Psychiatry 2018; 175:620-630).
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article